The world moved a step closer to developing an enduring defence against AIDS after researchers in Thailand unveiled the results of a vaccine trial on Thursday that cut the risk of becoming infected with the HIV virus by nearly one-third and will not lead to secondary complications.
“These results have instilled new hope in the HIV vaccine research field and promise that a safe and highly effective HIV vaccine may become available for populations throughout the world who are most in need of such a vaccine,” said the statement issued by WHO and UNAIDS.
Health Glance
Four Canadian studies involved about 2,000 people, health officials told CBC News. Researchers found people who had received the seasonal flu vaccine in the past were more likely to get sick with the H1N1 virus.
Sunbathing is known to cause skin cancer – but it may also help people survive when they get it, scientists are reporting.
American Airlines has sent letters to its retirees, saying it will be ending its Retiree Standard Medical Plan option for non-union employees.
Bans on smoking in public places have had a bigger impact on preventing heart attacks than ever expected, data shows.
Wealthy nations have contracted for much of the expected pandemic vaccine production, leaving little for poorer countries. But while Canada and some European nations will use vaccines containing adjuvants, American officials have decided against it for now. They say that they have enough vaccine and that the safety of the additives has not been proved.





























